Literature DB >> 2505091

Electrophysiological effects of flecainide enantiomers in canine Purkinje fibres.

J K Smallwood1, D W Robertson, M I Steinberg.   

Abstract

Since flecainide is a chiral class I antiarrhythmic agent, we examined the basic electrophysiological effects of its enantiomers (10-(6) - 3 x 10(-5) mol/l) in isolated canine Purkinje fibres using standard microelectrode techniques. Frequency-dependent block was studied by pacing at cycle lengths of 300 and 2000 ms. Both enantiomers produced a marked, concentration-dependent decrease in maximum upstroke velocity (Vmax), with greater depression occurring at a cycle length of 300 ms. The concentration causing a 50% decrease in Vmax (EC50) at this pacing rate were 5.0 +/- 0.6 x 10(-6) mol/l for (+)-flecainide and 6.2 +/- 0.8 x 10(-6) mol/l for (-)-flecainide, and were not significantly different. Both enantiomers also produced a concentration- and frequency-dependent decrease in action potential amplitude and an increase in conduction time with no significant differences between the enantiomers. However, at the highest concentration studied (3 x 10(-5) mol/l), none of the nine tissues exposed to (+)-flecainide could be paced at 300 ms cycle length while five of eight tissues exposed to (-)-flecainide could be paced, suggesting the possibility of a small difference between the effects of the enantiomers on membrane responsiveness. The effect of the enantiomers on action potential duration (APD) also depended on pacing rate. At the longer cycle length, ADP50 was shortened to a maximum of 61 +/- 7% and 67 +/- 7% from baseline by (+)- and (-)-flecainide, respectively, whereas APD95 was shortened by 30 +/- 6% and 32 +/- 3% from baseline by (+)- and (-)-flecainide, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505091     DOI: 10.1007/bf00168654

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  Effects of flecainide on the cellular electrophysiology of neonatal and adult cardiac fibers.

Authors:  S M Yabek; R Kato; N Ikeda; B N Singh
Journal:  Am Heart J       Date:  1987-01       Impact factor: 4.749

2.  Membrane potential-dependent effects of SC-36602, a new class I antiarrhythmic agent on cardiac action potentials.

Authors:  L E Borowicz; H C Schniepp; M C Sanguinetti
Journal:  J Cardiovasc Pharmacol       Date:  1987-01       Impact factor: 3.105

3.  Importance of physico-chemical properties in determining the kinetics of the effects of Class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle.

Authors:  T J Campbell
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

4.  Effect of flecainide on action potentials and alternating current-induced arrhythmias in mammalian myocardium.

Authors:  U Borchard; M Boisten
Journal:  J Cardiovasc Pharmacol       Date:  1982 Mar-Apr       Impact factor: 3.105

5.  Resolution of flecainide acetate, N-(2-piperidylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzam ide acetate, and antiarrhythmic properties of the enantiomers.

Authors:  E H Banitt; J R Schmid; R A Newmark
Journal:  J Med Chem       Date:  1986-02       Impact factor: 7.446

6.  Electrophysiological effects of the optical isomers of disopyramide and quinidine in the dog. Dependence on stereochemistry.

Authors:  M J Mirro; A M Watanabe; J C Bailey
Journal:  Circ Res       Date:  1981-06       Impact factor: 17.367

7.  Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.

Authors:  N Ikeda; B N Singh; L D Davis; O Hauswirth
Journal:  J Am Coll Cardiol       Date:  1985-02       Impact factor: 24.094

8.  Clinical and electrophysiologic effects of flecainide in patients with refractory ventricular tachycardia.

Authors:  E V Capparelli; J Kluger; J C Regnier; M S Chow
Journal:  J Clin Pharmacol       Date:  1988-03       Impact factor: 3.126

9.  Stereospecific effects of disopyramide enantiomers following pretreatment of canine cardiac Purkinje fibers with verapamil and nisoldipine.

Authors:  G A Kidwell; S F Schaal; W W Muir
Journal:  J Cardiovasc Pharmacol       Date:  1987-03       Impact factor: 3.105

10.  Na+ channels as sites of action of the cardioactive agent DPI 201-106 with agonist and antagonist enantiomers.

Authors:  G Romey; U Quast; D Pauron; C Frelin; J F Renaud; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

View more
  5 in total

1.  Electrophysiologic and anticholinergic effects of pirmenol enantiomers in guinea-pig myocardium.

Authors:  H Nakaya; Y Hattori; M Endou; S Gandou; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

2.  Stereoselective interaction of tocainide and its chiral analogs with the sodium channels in human myoballs.

Authors:  D Tricarico; B Fakler; W Spittelmeister; J P Ruppersberg; R Stützel; C Franchini; V Tortorella; D Conte-Camerino; R Rüdel
Journal:  Pflugers Arch       Date:  1991-04       Impact factor: 3.657

3.  Polymorphic flecainide disposition under conditions of uncontrolled urine flow and pH.

Authors:  A S Gross; G Mikus; C Fischer; M Eichelbaum
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Therapeutic drug monitoring: antiarrhythmic drugs.

Authors:  T J Campbell; K M Williams
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

5.  Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.

Authors:  A De Luca; F Natuzzi; G Lentini; C Franchini; V Tortorella; D Conte Camerino
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.